Related Experiment Video
Updated: Nov 18, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Plateletcrit may predict no-reflow after saphenous vein graft interventions in patients with non-ST elevation
Cafer Panç1, Emir Derviş, İsmail Gürbak
1Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.
Insights
Plateletcrit (PCT) may predict no-reflow during saphenous vein graft interventions in non-ST elevation myocardial infarction patients. Higher PCT levels indicate an increased risk of developing no-reflow, aiding in patient stratification.
Area of Science:
- Cardiology
- Hematology
- Interventional Cardiology
Background:
- Saphenous vein graft (SVG) percutaneous coronary interventions (PCIs) carry risks like distal embolization and no-reflow.
- Platelets play a key role in thrombus formation and the no-reflow phenomenon.
- Previous studies suggest a link between plateletcrit (PCT) and adverse cardiovascular outcomes.
Purpose of the Study:
- To evaluate if PCT can predict the occurrence of no-reflow in patients with non-ST elevation myocardial infarction (NSTEMI) undergoing PCI for SVG disease.
- To identify patients at higher risk for no-reflow during SVG PCI procedures.
Main Methods:
- Retrospective analysis of 181 NSTEMI patients who underwent PCI for SVG disease.
- Recording of platelet indices upon admission.
- Division of patients into no-reflow (n=32) and normal reflow (n=149) groups.
Main Results:
- The no-reflow group exhibited significantly higher PCT (0.254 vs. 0.224, P=0.020) and platelet count (265.4 vs. 233, P=0.011).
- ROC analysis identified a PCT cut-off of 0.230 for predicting no-reflow (68.8% sensitivity, 51.0% specificity).
- Multivariate analysis confirmed PCT as an independent predictor of no-reflow (OR: 5.091, CI: 1.356-19.116, P=0.016).
Conclusions:
- PCT is a potential independent predictor of no-reflow in NSTEMI patients undergoing SVG PCI.
- Elevated PCT levels may help identify patients at risk for no-reflow complications.
- PCT can be a valuable tool for risk stratification in this patient population.
Abstract:
Saphenous vein graft (SVG) percutaneous coronary interventions (PCIs) are procedures with potential complications such as distal embolization, slow or no-reflow phenomenon. Platelets are the main factors in development of thrombus and no-reflow phenomenon. There have been multiple studies that identified the association between plateletcrit (PCT) and cardiovascular outcomes. The aim of the study was to investigate whether PCT can predict the development of no-reflow in patients with non-ST elevation myocardial infarction (NSTEMI) undergoing PCI for SVG disease. A total of 181 patients who underwent PCI for SVG disease with NSTEMI were included retrospectively. Platelet indices on admission were recorded. Patients were divided into two groups according to the development of no-reflow during the procedure: no-reflow (n = 32; 18%) and normal reflow (n = 149; 82%). PCT and platelet count were higher in the no-reflow group (0.254 vs. 0.224, P = 0.020; 265.4 vs. 233, P = 0.011, respectively). The PCT cut-off value for predicting no-reflow was calculated as 0.230 by ROC curve analysis with 68.8% sensitivity and 51.0% specificity. Multivariate logistic regression analysis showed that PCT was an independent predictor of no-reflow (odds ratio: 5.091, confidence interval: 1.356-19.116, P = 0.016). PCT may be useful in identifying patients at risk for developing no-reflow in patient with NSTEMI undergoing SVG PCI.
More Related Videos
07:02A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care